sunitinib g.l. pharma 25 mg
remedica ltd. - cipru - sunitinibum - caps. - 25mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
sunitinib g.l. pharma 50 mg
remedica ltd. - cipru - sunitinibum - caps. - 50mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
clopidogrel/acetylsalicylic acid zentiva (previously duocover)
sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - agenți antitrombotici - coronarian acut miocardic syndromemyocardial.
sunitinib alvogen 12,5 mg
remedica ltd. - cipru - sunitinibum - caps. - 12,5mg - alte antineoplazice inhibitori de protein-kinaza
sunitinib alvogen 25 mg
remedica ltd. - cipru - sunitinibum - caps. - 25mg - alte antineoplazice inhibitori de protein-kinaza
sunitinib alvogen 37,5 mg
remedica ltd. - cipru - sunitinibum - caps. - 37,5mg - alte antineoplazice inhibitori de protein-kinaza
sunitinib alvogen 50 mg
remedica ltd. - cipru - sunitinibum - caps. - 50mg - alte antineoplazice inhibitori de protein-kinaza
dovprela (previously pretomanid fgk)
mylan ire healthcare limited - pretomanid - tuberculoză, rezistentă la diferite medicamente - antimicobacteriene - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). trebuie luate în considerare ghidurile oficiale referitoare la utilizarea adecvată a medicamentelor antibacteriene.
sunitinib alkaloid-int 12,5 mg
alkaloid - int d.o.o. - slovenia - sunitinibum - caps. - 12,5mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
sunitinib alkaloid-int 25 mg
alkaloid - int d.o.o. - slovenia - sunitinibum - caps. - 25mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza